Archives: Agenda
Interactive Breakfast Speaker-Hosted Roundtable Discussions
With drinks and refreshments, interactive roundtable sessions offer a unique opportunity to come together with your peers to share best practice and develop solutions to critical challenges facing the industry as a whole. Each discussion will run twice and be led by a table moderator and will focus on a different challenge within clinical trials. Roundtables are an exciting, interactive way to build your personal network and learn from the experience and expertise of others.
| Roundtable 1 | Navigating the latest release of ICH E6 (R3): How are you carrying out gap assessments of processes and what changes are you making?
Hosted by Christina Sanchez, Director, Clinical Quality Assurance, Neurocrine Biosciences |
| Roundtable 2 | Postproduction handling and administration of biologics drugsĀ
Hosted by Kevin Zen, Director, Opthea |
| Roundtable 3 | Collaborative solutions between Sponsors and CROs for accurate site budgeting and forecasting
Hosted by Richard Firth, Associate Director, Development Business Operations, Arcturus Therapeutics |
| Roundtable 4 | Emerging startup company trends and challenges |
| Roundtable 5 | Implications of the latest administration on clinical trial progress |
CLOSING PANEL DISCUSSION: Ensuring your FSP model is a success
- Working closely with FSP vendors: how much oversight do you need?
- Benefits and challenges of moving to an FSP outsourcing model
- Comparing vendor management strategies between pharma and biotechs: do you need a different approach?
- Why is FSP becoming a popular outsourcing model: what benefits can this offer sponsors?
Moderator: Amanda Murphy, Senior Director, Data Intelligence & Solutions, GlobalData
CLOSING PANEL DISCUSSION Genuine, constructive partnerships: Effective approaches to CRO management without compromising efficiency, quality and patient safety
- Setting up for success with large CROs in terms of contract structures, financial terms and governance from a small biotech perspective
- Implementing a gold standard strategic partnership to avoid common pitfalls and improve vendor selection
- Knowing when to outsource and detailing key activities to be performed for each vendor service to ensure proper oversight
- Factoring in necessary contracts and approvals for vendor selection in study timelines
Moderator: Robert Loll, SVP, Business Development & Strategic Planning, Praxis
Utilizing third party vendors for clinical trial support
- Determining team bandwidth
- Assessing clinical trial needs
- Shopping for the right CRO(s)
- Lessons learned from outsourcing
Practical ways ICON is using AI to address common delivery pain points
- Predict high-performing sites and investigators to accelerate enrolment
- Forecast site activation timelines with greater accuracy
- Anticipate post-marketing commitments earlier in the process
- Enhance TMF compliance and quality through intelligent automation
- Accelerate and streamline site contracting for faster study start-up
- Drive operational efficiency and cost savings through robotic process automation
Keynote: Insights from the VTA
Keynote Fireside Chat: Digital Transformation Stories
Afternoon Refreshments and Networking
Crafting the Perfect Collagen Beverage
- Introduction of company
- Introduction of ingredient collagen and bioactive collagen peptides
- Collagen in beverages opportunities
- Technical feasibility in beverages
- New product teaser